A Prospective Randomized Trial Comparing the Vienna Nomogram and a Ten-Core Prostate Biopsy Protocol: Effect on Cancer Detection Rate-Reference-Cited by-同舟云学术

A Prospective Randomized Trial Comparing the Vienna Nomogram and a Ten-Core Prostate Biopsy Protocol: Effect on Cancer Detection Rate

Published:2017-02 Issue:1 Volume:15 Page:117-121
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Leitão Tito Palmela,Alfarelos Joana,Rodrigues Teresa,Pereira e Silva Ricardo^ORCID,Garcia Rodrigo Miguel,Martinho David,Sandul Anatoliy,Mendonça Tiago,Pereira Sérgio,Lopes Tomé Matos

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference17 articles.

1. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate;Hodge;J Urol,1989

2. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values;Keetch;J Urol,1995

3. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review;Eichler;J Urol,2006

4. Effect of dimensions and volume of the prostate on cancer detection rate of 12 core prostate biopsy;Ozden;Int Urol Nephrol,2007

5. The influence of prostate size on cancer detection;Uzzo;Urology,1995

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3;Frontiers in Oncology;2022-06-08

2. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning;Computers in Biology and Medicine;2021-11

3. Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study;Future Science OA;2021-10

4. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance;International Urology and Nephrology;2020-05-28

5. Optimal threshold of the prostate health index in predicting aggressive prostate cancer using predefined cost–benefit ratios and prevalence;International Urology and Nephrology;2019-12-24